FACULTAD DE MEDICINA
Facultad
University of Cologne
Colonia, AlemaniaPublicaciones en colaboración con investigadores/as de University of Cologne (40)
2023
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
2021
-
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
Annals of the Rheumatic Diseases, Vol. 80, Núm. 8, pp. 1040-1047
-
Genomic Risk Score impact on susceptibility to systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort
Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway
Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
Arthritis and Rheumatology
2013
-
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029
-
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 164-167
-
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes
Clinical and Experimental Rheumatology
-
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238